Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yasamin Davatgaran Taghipour, Marziyeh Hajialyani, Rozita Naseri, Mahvash Hesari, Pantea Mohammadi, Azzurra Stefanucci, Adriano Mollica, Mohammad Hosein Farzaei & Mohammad Abdollahi. (2019) Nanoformulations of natural products for management of metabolic syndrome. International Journal of Nanomedicine 14, pages 5303-5321.
Read now
Read now
Lalit S Doshi, Manoja Kumar Brahma, Umakant A Bahirat, Amol V Dixit & Kumar VS Nemmani. (2010) Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents. Expert Opinion on Investigational Drugs 19:4, pages 489-512.
Read now
Read now
Hiroyuki Miyachi. (2005) Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004. Expert Opinion on Therapeutic Patents 15:11, pages 1521-1530.
Read now
Read now
Harrihar A Pershadsingh. (2004) Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond diabetes: quo vadis?. Expert Opinion on Investigational Drugs 13:3, pages 215-228.
Read now
Read now
Articles from other publishers (31)
Aman Upaganlawar, Chandrashekhar Upasani & Stella Amarachi Ihim. 2022. Current Thoughts on Dementia. Current Thoughts on Dementia
387
415
.
May A. Abd El Fattah, Yasmine A. Abdelhamid, Mohammed F. Elyamany, Osama A. Badary & Ola A. Heikal. (2020) Rice Bran Extract Protected against LPS-Induced Neuroinflammation in Mice through Targeting PPAR-γ Nuclear Receptor. Molecular Neurobiology 58:4, pages 1504-1516.
Crossref
Crossref
Ting-Ting Wu, Qing-Qing Guo, Zi-Li Chen, Li-Li Wang, Yao Du, Rui Chen, Yuan-Hu Mao, Sheng-Gang Yang, Jing Huang, Jian-Ta Wang, Ling Wang, Lei Tang & Ji-Quan Zhang. (2020) Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors. European Journal of Medicinal Chemistry 204, pages 112637.
Crossref
Crossref
Liancai Zhu, Jun Tan, Deshuai Lou, Tingwang Guo & Bochu Wang. (2017) The effects of flavonoid compound from Agrimonia pilosa Ledeb on promotting 3T3-L1 preadipocytes differentiation by activating PPARγ partially. Medicinal Chemistry Research 26:11, pages 2920-2928.
Crossref
Crossref
Raman K. Verma, Vijay Kumar, Prithwish Ghosh & Lalit K. Wadhwa. (2012) 3D-QSAR study of tyrosine and propanoic acid derivatives as PPARα/γ dual agonists using CoMSIA. Medicinal Chemistry Research 22:1, pages 287-302.
Crossref
Crossref
Steven K. Engle, Philip F. Solter, Kelly M. Credille, Christopher M. Bull, Stephanie Adams, Michael J. Berna, Albert E. Schultze, Emily C. Rothstein, Michael D. Cockman, Michael L. Pritt, Hong Liu, Yuefeng Lu, Alan Y. Chiang & David E. Watson. (2010) Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging. Toxicological Sciences 114:2, pages 183-192.
Crossref
Crossref
Amin Majdalawieh & Hyo-Sung Ro. (2010) PPARγ1 and LXRα face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nuclear Receptor Signaling 8:1, pages nrs.08004.
Crossref
Crossref
Peter E. MaligresGuy R. HumphreyJean-François MarcouxMichael C. HillierDalian ZhaoShane KrskaEdward J. J. Grabowski. (2009) Practical, Highly Convergent, Asymmetric Synthesis of a Selective PPARγ Modulator. Organic Process Research & Development 13:3, pages 525-534.
Crossref
Crossref
Paul S. Humphries, Quyen-Quyen T. Do & David M. Wilhite. (2009) Synthesis of 2-methoxy-2-methyl-3-{6-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]pyridin-3-yl}propanoic acid, a dual PPARα/γ agonist. Tetrahedron Letters 50:16, pages 1765-1767.
Crossref
Crossref
Hiroyuki Kagechika & Aya Tanatani. 2008. Gene Family Targeted Molecular Design. Gene Family Targeted Molecular Design
275
316
.
Tatiana M. Garcia-Bates, Geniece M. Lehmann, Patricia J. Simpson-Haidaris, Steven H. Bernstein, Patricia J. Sime & Richard P. Phipps. (2008) Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies. PPAR Research 2008, pages 1-18.
Crossref
Crossref
Rakesh Kumar, Amit Mittal & Uma Ramachandran. (2007) Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARγ activators. Bioorganic & Medicinal Chemistry Letters 17:16, pages 4613-4618.
Crossref
Crossref
Robert A. Hegele & Junko Oshima. (2007) Phenomics and lamins: From disease to therapy. Experimental Cell Research 313:10, pages 2134-2143.
Crossref
Crossref
Rakesh Kumar, Uma Ramachandran, Suryaprakash Raichur, Ranjan Chakrabarti & Rahul Jain. (2007) Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators. European Journal of Medicinal Chemistry 42:4, pages 503-510.
Crossref
Crossref
Ronda K. Rippley, Kerri X. Yan, Natalie D. Matthews, Howard E. Greenberg, Gary A. Herman & John A. Wagner. (2007) Human Pharmacokinetics and Interconversion of Enantiomers of MK-0767, a Dual PPARα/γ Agonist. The Journal of Clinical Pharmacology 47:3, pages 323-333.
Crossref
Crossref
Fang Zhang, Brian E. Lavan & Francine M. Gregoire. (2007)
Selective Modulators of PPAR-
Activity: Molecular Aspects Related to Obesity and Side-Effects
. PPAR Research 2007, pages 1-7.
Crossref
Crossref
Alan M. Warshawsky, Charles A. Alt, Joseph T. Brozinick, Allen R. Harkness, Eric D. Hawkins, James R. Henry, Donald P. Matthews, Anne R. Miller, Elizabeth A. Misener, Chahrzad Montrose-Rafizadeh, Gary A. Rhodes, Quanrong Shen, Jennifer A. Vance, Uko E. Udodong, Minmin Wang, Tony Y. Zhang & Richard W. Zink. (2006) Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands. Bioorganic & Medicinal Chemistry Letters 16:24, pages 6328-6333.
Crossref
Crossref
Paul S Humphries, Quyen-Quyen T Do & David M Wilhite. (2006)
ADDP and PS-PPh
3
: an efficient Mitsunobu protocol for the preparation of pyridine ether PPAR agonists
. Beilstein Journal of Organic Chemistry 2.
Crossref
Crossref
Harrihar A. Pershadsingh. (2006) New generation angiotensin II type 1 receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-γ. Drug Development Research 67:8, pages 687-697.
Crossref
Crossref
Paul S. Humphries, Simon Bailey, Quyen-Quyen T. Do, Jack H. Kellum, Guy A. McClellan & David M. Wilhite. (2006) Intermolecular palladium-catalyzed coupling of 2-halopyridines and alcohols for the preparation of pyridine ether PPAR agonists. Tetrahedron Letters 47:30, pages 5333-5336.
Crossref
Crossref
Harrihar A. Pershadsingh. (2006) Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-γ. The International Journal of Biochemistry & Cell Biology 38:5-6, pages 766-781.
Crossref
Crossref
Elke Burgermeister, Astride Schnoebelen, Angele Flament, Jörg Benz, Martine Stihle, Bernard Gsell, Arne Rufer, Armin Ruf, Bernd Kuhn, Hans Peter Märki, Jacques Mizrahi, Elena Sebokova, Eric Niesor & Markus Meyer. (2006) A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro. Molecular Endocrinology 20:4, pages 809-830.
Crossref
Crossref
Harrihar A Pershadsingh. (2006) Dual Peroxisome Proliferator-Activated Receptor-??/?? Agonists. Treatments in Endocrinology 5:2, pages 89-99.
Crossref
Crossref
Derek B. Lowe, Neil Bifulco, William H. Bullock, Thomas Claus, Philip Coish, Miao Dai, Fernando E. Dela Cruz, David Dickson, Dongping Fan, Helana Hoover-Litty, Tindy Li, Xin Ma, Gretchen Mannelly, Mary-Katherine Monahan, Ingo Muegge, Stephen O’Connor, Mareli Rodriguez, Tatiana Shelekhin, Andreas Stolle, Laurel Sweet, Ming Wang, Yamin Wang, Chengzhi Zhang, Hai-Jun Zhang, Mingbao Zhang, Kake Zhao, Qian Zhao, Jian Zhu, Lei Zhu & Manami Tsutsumi. (2006) Substituted indanylacetic acids as PPAR-α–γ activators. Bioorganic & Medicinal Chemistry Letters 16:2, pages 297-301.
Crossref
Crossref
Robert A. Hegele & Rebecca L. Pollex. (2005) Genetic and physiological insights into the metabolic syndrome. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 289:3, pages R663-R669.
Crossref
Crossref
Tom Hsun-Wei Huang, Bhavani Prasad Kota, Valentina Razmovski & Basil D. Roufogalis. (2005) Herbal or Natural Medicines as Modulators of Peroxisome Proliferator-Activated Receptors and Related Nuclear Receptors for Therapy of Metabolic Syndrome. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:1, pages 3-14.
Crossref
Crossref
John J. ActonIIIIII, Regina M. Black, A. Brian Jones, David E. Moller, Lawrence Colwell, Thomas W. Doebber, Karen L. MacNaul, Joel Berger & Harold B. Wood. (2005) Benzoyl 2-methyl indoles as selective PPARγ modulators. Bioorganic & Medicinal Chemistry Letters 15:2, pages 357-362.
Crossref
Crossref
Joseph L. Evans, Jack F. Youngren & Ira D. Goldfine. (2004) Effective treatments for insulin resistance: trim the fat and douse the fire. Trends in Endocrinology & Metabolism 15:9, pages 425-431.
Crossref
Crossref
Robert A. Hegele. (2004) Treatment of partial lipodystrophy: can the zebra teach us about the horse?. Drug Discovery Today: Disease Mechanisms 1:2, pages 195-203.
Crossref
Crossref
Hiroo Koyama, Daniel J. Miller, Julia K. Boueres, Ranjit C. Desai, A. Brian Jones, Joel P. Berger, Karen L. MacNaul, Linda J. Kelly, Thomas W. Doebber, Margaret S. Wu, Gaochao Zhou, Pei-ran Wang, Marc C. Ippolito, Yu-Sheng Chao, Arun K. Agrawal, Ronald Franklin, James V. Heck, Samuel D. Wright, David E. Moller & Soumya P. Sahoo. (2004)
(2
R
)-2-Ethylchromane-2-carboxylic Acids: Discovery of Novel PPARα/γ Dual Agonists as Antihyperglycemic and Hypolipidemic Agents
. Journal of Medicinal Chemistry 47:12, pages 3255-3263.
Crossref
Crossref
. (2004) Current literature in diabetes. Diabetes/Metabolism Research and Reviews 20:2, pages 165-172.
Crossref
Crossref